Clinical Trials List
Protocol NumberTOG 301
2011-12-01 - 2013-12-31
Phase III
Terminated1
ICD-10Z51.11
Encounter for antineoplastic chemotherapy
ICD-9V58.1
Encounter for chemotherapy
-
Trial Applicant
PROTECH PHARMASERVICES CORPORATION
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chia-Jui Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
580 participants
